Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming oral presentation highlighting data from the FOCUS Phase 3 clinical trial of fostamatinib in hospitalized COVID-19 patients...

The company's healthcare-specific solutions enable nurses to do what they do best – care for patients HOUSTON, Oct. 11, 2023 /PRNewswire-PRWeb/ -- symplr®, a leader in enterprise healthcare...

Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will present study findings during two posters sessions at IDWeek 2023, October...

The London Blockchain Conference (LBC) is thrilled to announce the open call for content submissions for its highly anticipated 2024 expo. The Conference aims to provide a platform for disruptors,...